WHO Public Consultation
Happy New Year.
We would like to inform you that a public consultation on the following document is now open.
Based on a WHO consultation with regulators, manufacturers and other experts the following document was prepared and has been posted on the WHO biologicals web site https://www.who.int/biologicals/en/ for public comments: The comment form is attached to this mail or can be found directly under the link to the document on the WHO biologicals website.
Guidelines: Submission deadline: 28 February 2019
Guidelines on the quality, safety and efficacy of human Respiratory Syncytial Virus vaccines https://www.who.int/biologicals/RSV_Guideline_Draft_2.3_(clean)_20190114_(2)_tz.pdf?ua=1
We would be grateful if you could share this information with your colleagues and compile their feedback.
All comments received by the published deadline (shown above) will be considered in further revision of the Guidelines.
With best regards,
Dr Ivana Knezevic
Scientist, Technologies, Standards and Norms Team
Group Lead, Norms and Standards for Biologicals
Access to Medicines, Vaccines and Pharmaceuticals
Access to Medicines and Vaccines
Office: +41 22 791 3136
Biological standardization website: www.who.int/biologicals
Immunization website: www.who.int/immunization
Follow WHO on Facebook, Twitter, YouTube, Instagram
Please don't print this e-mail unless you really need to. Thank you.
WHO Cell Substrate Documents 1959 to 2012
In collaboration with WHO, IABS has published a collection of eight WHO documents on cell substrates for the production of biological products to serve as an historical reference and to facilitate an understanding of the evolution of issues and positions that have been taken since the 1950s.
The following link will bring you to the distributor and more information on this book.